17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS FOR THE TREATMENT OF HORMONE-RELATED DISEASES
申请人:Hartmann Rolf
公开号:US20110046147A1
公开(公告)日:2011-02-24
The invention relates to 17beta-hydroxysteroid dehydrogenase type 1 (17betaHSD1) inhibitors, the preparation thereof and the use thereof for the treatment and prophylaxis of hormone-related, especially estrogen-related or androgen-related, diseases.
该发明涉及17beta-羟基类
固醇脱氢酶1型(17betaH
SD1)
抑制剂,其制备以及用于治疗和预防激素相关疾病,特别是
雌激素相关或雄激素相关疾病的用途。